Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) Revenue growth
Zimmer Biomet Holdings, Inc.'s revenue growth over the twelve months to 30 June 2026 was 8.62%, up 1.4 percentage points from fiscal 2025 (7.20%). Over the past ten years it has ranged from −23.2% (fiscal 2020) to 28.3% (fiscal 2015); the current reading is higher than 73% of that period. That is in line with the Medical Devices industry median of 8.80% and in line with the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 7.20% | 3.35 |
| FY2024 | 3.85% | (2.70) |
| FY2023 | 6.55% | 4.90 |
| FY2022 | 1.65% | (9.77) |
| FY2021 | 11.4% | 34.66 |
| FY2020 | −23.2% | (23.86) |
| FY2019 | 0.62% | (1.04) |
| FY2018 | 1.66% | (0.10) |
| FY2017 | 1.76% | (26.09) |
| FY2016 | 27.9% | (0.49) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 4.80% | (4.50) |
| Mar 2026 | 9.30% | (1.60) |
| Dec 2025 | 10.9% | 1.19 |
| Sep 2025 | 9.71% | 2.74 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GMED Globus Medical, Inc. compare | 19.7% |
| PEN Penumbra, Inc. compare | 17.6% |
| DXCM DexCom, Inc. compare | 15.5% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. | 8.62% |
| STE STERIS plc compare | 8.37% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.37% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement